AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Inovio Pharmaceuticals In... (INO)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

2.16

-0.11 (-4.85%)

At close: Jan 28, 2025, 1:51 PM

undefined% (undefined)

Bid	2.16
Market Cap	77.98M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-4.43
PE Ratio (ttm)	-0.49
Forward PE	n/a
Analyst	Buy

Ask	2.17
Volume	451,834
Avg. Volume (20D)	981,589
Open	2.25
Previous Close	2.27
Day's Range	2.13 - 2.25
52-Week Range	1.74 - 14.75
Beta	undefined

About INO

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery o...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Dec 8, 1998

Employees 127

Stock Exchange NASDAQ

Ticker Symbol INO

Website https://www.inovio.com

Analyst Forecast

According to 5 analyst ratings, the average rating for INO stock is "Buy." The 12-month stock price forecast is $15, which is an increase of 594.44% from the latest price.

Buy 60.00%

Hold 40.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Inovio Pharmaceuticals Inc. is scheduled to release its earnings on Mar 5, 2025, during market hours.
Analysts project revenue of $30.00K, reflecting a -70.87% YoY shrinking and earnings per share of -0.93, making a -15.45% decrease YoY.

Why Price Moved

2 weeks ago

+18.13%

Shares of vaccine makers are trading higher after ... Unlock content with Pro Subscription

1 month ago

-38.3%

Inovio Pharmaceuticals shares are trading lower after the company announced a public offering of 10 million shares for gross proceeds of $30 million.

News

1 month ago · benzinga.com

Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummet

U.S. stocks traded mixed toward the end of trading, with the S&P 500 edging lower on Friday.

2 months ago · benzinga.com

European And US Vaccine Stocks Are Under Pressure - Here's WHy

Some large European and U.S. vaccine maker stocks have fallen in reaction to Robert F. Kennedy Jr.'s nomination to lead the Department of Health and Human Services.

2 months ago · seekingalpha.com

Inovio Pharmaceuticals, Inc. (INO) Q3 2024 Earnings Call Transcript

Inovio Pharmaceuticals, Inc. (NASDAQ:INO ) Q3 2024 Earnings Call Transcript November 14, 2024 4:30 PM ET Company Participants Thomas Hong - Manager of IR Jacqui Shea - President and CEO Mike Sumner - ...